Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertension

Trial Profile

Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2017

At a glance

  • Drugs Azilsartan (Primary) ; Olmesartan medoxomil
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms CANZONE study
  • Most Recent Events

    • 24 Mar 2016 Status changed from recruiting to completed.
    • 20 Apr 2015 According to the University Hospital Medical Information Network - Japan record, planned number of patients changed from 80 to 60.
    • 20 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top